Evaluating Connections Between Polysubstance Use, Social Drivers of Health, and Mental Health Symptoms in People With HIV

• by Ann Avery, Yanis Bitar, David Hussey, Corrilynn O Hileman

• April 24, 2025

Two-Drug HIV Regimen Gains FDA Approval

Phase 3 trials showed noninferior viral suppression vs standard three-drug therapy with similar safety outcomes

• by Kathryn Wighton

• April 21, 2026

• 2 min

Side Effects: Nobody Trained for This

Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.

• by Kerri Miller

• May 11, 2026

• 6 min

Trump administration’s drug strategy is at odds with recent actions on funding, policy

• by Lev Facher

• May 6, 2026